Hausen "Erlotinib Hydrochloride Tablets" Approved for Listing
Time of Update: 2021-06-04
On May 31, Hausen's "Erlotinib Hydrochloride Tablets" was approved by the National Medical Products Administration (NMPA), becoming the second domestic generic drug of this variety.
Liaoning four friends new material proposed to build 20,000 tons / year electronic grade epoxy resin project
Time of Update: 2020-10-06
On July 31, the Tai'an County government announced the first public participation of Liaoning Four Friends New Materials Co., Ltd., with an annual output of 20,000 tons of electronic epoxy resin envir
A province has not been evaluated generic drug price reduction knife medical insurance payment standards to develop a great new idea
Time of Update: 2020-09-28
This program is slightly different from other provinces, take the price of generic drugs without evaluation, in the medical insurance payment standards developed quite profound: the original research, evaluation and other products within three years to the generic drug winning varieties close.
4 + 7 "atorvastatin calcium tablet" passed the consistency evaluation
Time of Update: 2019-11-21
On November 20, Hunan Dino was approved according to the listing application of "atorvastatin calcium tablets" submitted by the new 4 categories, and it was deemed to have passed the consistency evalu
[good medicine record] the consistency evaluation acceptance number has broken through 600299 and is 289 varieties; this week, Kelun has 2 billion varieties and Fosun is the first one
Time of Update: 2018-12-13
As of December 13, there are 616 application acceptance numbers of CDE acceptance consistency evaluation (calculated according to supplementary application, the same below), 217 varieties of drugs inv
[drug gajun] Yichang humanwell is expecting to challenge the status of dizosin, the first anesthetist brother? This week, there are Huahai, Fosun, jiankangyuan
Time of Update: 2018-11-12
Highlight: after the approval of Yichang humanwell potential generic drug, it is expected to challenge the status of dizosin, the first anesthetist? Zhejiang Huahai depression drug has been approved i
Europe will become the next market for Aurobindo
Time of Update: 2017-07-05
[chinapharma.com Enterprise News] Indian pharmaceutical companies have traditionally attached great importance to API production and preparation production Therefore, Aurobindo hopes to improve the op
There is a way to choose: potential and cost focus of two types of improved new drugs under the new policy
Time of Update: 2015-11-19
Among them, the reorientation of the registration and classification of chemicals can be said to bring subversive changes to enterprises How to adapt to new changes?
Many enterprises said: resolutely do new drugs!
CDE Drug Evaluation Weekly Report (2015.11.1-2015.11.7
Time of Update: 2015-11-10
Source: Xianda data: 76 drugs (calculated by acceptance number, the same below) entered the review status in the review week (2015.11.1-2015.11.7) on November 10, 2015, with a slight decrease in the n